Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM vs Low-dose Dexamethasone in Post-COVID-19 Lung Abnormalities
NCT05798195Unknown
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexamethasone and Strengthening spleen and tonifying lung decoction in COVID-19 pneumonia (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Lung CT scan at 1 month. Status: unknown.
02
Drugs
dexamethasoneStrengthening spleen and tonifying lung decoction
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05798195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05798195.